Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Adalimumab Formulation in Rheumatoid Arthritis
NCT01712178Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2012
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of adalimumab in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Jun 2012; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01712178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712178.